Cheryl Gault
Chief Operating Officer · 5 filings · Latest: Sep 30, 2026
Rapport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RAPP | Cheryl Gault | Chief Operating Officer | Sep 30, 2026 | Sale | $33.19 | 10,000 | $331.9K | 139,914 | |
RAPP | CHERYL GAULT | — | Sep 30, 2026 | Proposed Sale | $33.02 | 10,000 | $330.2K | — | |
RAPP | Cheryl Gault | Chief Operating Officer | Jun 30, 2026 | Sale | $41.58 | 10,000 | $415.8K | 149,914 | |
RAPP | CHERYL GAULT | — | Jun 30, 2026 | Proposed Sale | $40.39 | 10,000 | $403.9K | — | |
RAPP | Cheryl Gault | Chief Operating Officer | Mar 30, 2026 | Sale | $28.19 | 10,000 | $281.9K | 159,914 | |
RAPP | CHERYL GAULT | — | Mar 30, 2026 | Proposed Sale | $27.84 | 10,000 | $278.4K | — | |
RAPP | Cheryl Gault | Chief Operating Officer | Mar 5, 2026 | Sale | $28.93 | 2,014 | $58.3K | 169,914 | |
RAPP | Gault Cheryl | — | Mar 5, 2026 | Proposed Sale | $28.92 | 2,014 | $58.2K | — | |
RAPP | CHERYL GAULT | — | Sep 8, 2025 | Proposed Sale | $14.36 | 10,000 | $143.6K | — |